AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Ibiden today, you really need to believe that demand for advanced IC package substrates tied to AI and general servers can support the company’s elevated earnings base and justify a premium valuation. The August 2026 guidance hike, helped by firm pricing, a weaker yen and stable output at the Ono plant, reinforces that AI server exposure is now the dominant short term catalyst. At the same time, the back‑to‑back stock splits and mechanically adjusted dividend policy look designed to broaden the shareholder base without changing capital return priorities. The flip side is that strong recent share price gains and a high earnings multiple leave less room for disappointment if AI server demand, capacity utilization or pricing soften from here.
However, investors should be aware how dependent today’s story is on AI server substrate demand. IbidenLtd's shares are on the way up, but could they be overextended? Uncover how much higher they are than fair value.Explore 3 other fair value estimates on IbidenLtd - why the stock might be worth as much as 22% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com